Drug Profile
Adenosine - Xsira
Alternative Names: Adenogesic; IV-adenosineLatest Information Update: 27 Oct 2021
Price :
$50
*
At a glance
- Originator Harbor-UCLA Research and Education Institute
- Class Anti-ischaemics; Antiarrhythmics; Purine nucleosides; Ribonucleosides; Small molecules
- Mechanism of Action Adenosine A1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Postoperative pain
Most Recent Events
- 31 Oct 2005 Phase-II clinical trials in Postoperative pain in USA (IV)
- 14 Apr 2005 Clinical trials in Postoperative pain in USA (IV)